Mechanistically, a reduction of miR‐142‐3p is implicated in the occurrence of NASH, characterized by hepatic lipid metabolism dysfunction and chronic inflammation through an increase in ACSL4. This evidence concerns the gene ACSL4 and metabolic dysfunction-associated steatohepatitis.